Clinical trials
Heart Defects, Congenital trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 8 |
| Not yet recruiting | 6 |
| Recruiting | 4 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 6 |
| Kun Sun | 3 |
| Beijing Anzhen Hospital | 2 |
| China National Center for Cardiovascular Diseases | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| Sun Yat-sen University | 2 |
| The Children's Hospital of Zhejiang University School of Medicine | 2 |
| Xijing Hospital | 2 |
| Yan Fuxia | 2 |
| Guangdong Provincial People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Defects, Congenital | 31 |
| Heart Valve Diseases | 4 |
| Aortic Dissection | 2 |
| Emergence Delirium | 2 |
| Parasomnias | 2 |
| Aneurysm | 1 |
| Aortic Aneurysm | 1 |
| Aortic Coarctation | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.